Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

CNBX Relative to the S&P 500

CNBX Relative to the Sector

Seasonal Chart Analysis

Analysis of the CNBX Pharmaceuticals Inc. (OTCMKT:CNBX) seasonal charts above shows that a Buy Date of May 1 and a Sell Date of July 23 has resulted in a geometric average return of 4.92% above the benchmark rate of the S&P 500 Total Return Index over the past 17 years. This seasonal timeframe has shown positive results compared to the benchmark in 9 of those periods. This is a poor rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 17 years by an average of 104.92% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

CNBX Pharmaceuticals Inc is a clinical-stage biotechnology company. It develops pharmaceuticals focusing on cancer research utilizing HTS technology and personalized bioinformatics tools. The company’s main focus is the development of cannabinoid therapies and other technologies for the treatment of cancer, mainly cancers of the gastrointestinal tract, skin, breast, and prostate. The firm’s main product is the Cannabics SR, an oral capsule developed for the treatment of patients with cancer and cancer anorexia cachexia syndrome (CACS). It also has an anti-neoplastic drug candidate under development for Colorectal Cancer (CRC) named RCC-33.

To download CNBX seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: CNBX